本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Prime Medicine, Inc.

3.39
+0.15004.63%
盤後3.390.00000.00%19:38 EDT
成交量:360.27萬
成交額:1,221.56萬
市值:6.12億
市盈率:-3.12
高:3.49
開:3.26
低:3.24
收:3.24
52周最高:6.94
52周最低:2.67
股本:1.81億
流通股本:1.16億
量比:1.21
換手率:3.11%
股息:- -
股息率:- -
每股收益(TTM):-1.0853
每股收益(LYR):-1.3521
淨資產收益率:-373.29%
總資產收益率:-46.52%
市淨率:15.37
市盈率(LYR):-2.51

資料載入中...

公司資料

公司名字:
Prime Medicine, Inc.
交易所:
NASDAQ
成立時間:
2019
員工人數:
146
公司地址:
60 First Street,Cambridge,Massachusetts,United States
郵編:
02141
電話:
傳真:
- -
簡介:
Prime Medicine, Inc.於2019年9月在特拉華州註冊成立。該公司是一家生物技術公司,致力於提供一類新的差異化一次性治療基因療法— Prime Editors,通過部署Prime Editing技術來解決最廣泛的疾病譜。

董事

名稱
職位
Allan Reine
Chief Financial Officer,Chief Executive Officer and Director
Jeffrey Marrazzo
Director and Executive Chair
David Schenkein
Director
Kaye Foster
Director
Michael Kelly
Director
Robert Taylor NELSEN
Director
Thomas Cahill
Director
Wendy Chung
Director

股東

名稱
職位
Allan Reine
Chief Financial Officer,Chief Executive Officer and Director
Ann Lee
Chief Technical Officer
Carman Alenson
Chief Accounting Officer
Jeffrey Marrazzo
Director and Executive Chair